The physiological saline market was valued at USD2,140.2Mn by 2019. Rising prevalence of water and foodborne diseases worldwide chiefly associated with dehydration primarily determines the physiological saline market growth. Additionally constant rise in the number of patients suffering from wounds and burns obtained due to traumatic accidents and occupational hazards will fortify the physiological saline market growth.

Physiological saline belongs to the crystalloid family of medications, it is acidic having a pH of 5.5, made by dissolving 9 grams of sodium chloride in 1 liter of sterile, pyrogen-free, non-toxic water. It is enlisted in the World Health Organization (WHO) list of essential medicines.

The major segments related to the physiological saline market are: 

By Application (2017–2027; US$ Mn)

Replacement Fluid Therapy

Wound Cleansing & Irrigation

Diluent & Solvent

Others

By End Users (2017–2027; US$ Mn)

Hospitals

Clinics

Others

Geography Segment(2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

• The intention of the study is to give a comprehensive outlook of the global physiological saline market
• The overall segmentation of the physiological saline market, by application, end-users, and geography is minutely studied. Replacement fluid therapy and hospitals are dominating the application and end-user segments respectively
• Significant increase in gastrointestinal disorders causing dehydration due to diarrhea and vomiting
• A constant rise in the number of patients visiting hospitals inflicted with traumatic wounds and burns

Report gist?

• The study of the global physiological saline market includes qualitative analysis of factors such as drivers, restraints, and opportunities
• The report covers qualitative and quantitative analysis of the overall market segmented on the basis of application and end-users and categorization of the same at geography level
• This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027
• The study includes the profiles of major market players with a significant global and regional presence along with top company positioning

Significant customers?

• This study is suitable for industry participants and stakeholders in the pharmaceutical companies engaged in manufacturing and marketing of physiological saline on account of the rising prevalence of infectious disease-causing dehydration and significant increase in the number of patients visiting hospitals to tend accidental wounds and burns
• The report will benefit hospital administration engaged in maintaining adequate inventory of physiological saline
• Managers with financial institutions looking to publish recent and forecasted statistics pertaining to physiological saline market
• Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies

Segment Analysis

Replacement fluid therapy is dominating the application segment for the physiological saline market. As per the latest information provided by the World Bank approximately more than 663 million people worldwide do not have access to drinking clean water, which results in dehydration due to diarrhea and vomiting. Fluid replacement therapy is vital in treating patients suffering from food poisoning as it performs vital functions such as regulating body temperature, maintaining blood flow and excreting toxins from the body, etc. Wound cleansing and irrigation will be the fastest-growing application segment in the near future owing to a significant rise in wounds and burns obtained due to traumatic accidents and occupational hazards worldwide.

Hospitals are ruling the end-user segment for the physiological saline market. The major features which support its market supremacy are huge government funding to maintain an adequate inventory for physiological saline solutions and it serves as the first point of contact for patients suffering from dehydration associated with bacterial infections. Clinics are have gained strong ground in the last 2 decades and will be growing at a rapid pace during the forecast period. Developing healthcare infrastructure and the establishment of specialty clinics by huge corporate conglomerates will navigate the positive market growth for clinics in the developing regions.

Asia Pacific is representing the largest market share in the geography segment for the physiological saline market. The chief factors responsible for its market dominance are the rising prevalence of gastrointestinal infectious disease-causing severe dehydration which results in loss of body fluid due to diarrhea and vomiting. Furthermore constant rise in the inpatient admission in hospitals and clinics tending wounds inflicted due to occupational hazards and traumatic accidents will bolster the physiological saline market growth. Europe is the second-largest market on account of the rising prevalence of antibiotic-resistant infections across all age groups. According to the latest research citings brought forward by the European Commission report, approximately 33,000 Europeans die due to antibiotic-resistant infection each year. Severe dehydration is the most visible clinical manifestation encountered in patients suffering from antibiotic-resistant infections in the region. North America is going to be the fastest-growing regional segment for the physiological saline market. As per the statistics brought forward by the Center for Disease Control and Prevention (CDC), annually 128,000 U.S. citizens are hospitalized due to foodborne disease-causing diarrhea and vomiting in ailing patients. Domicile of key players such as Baxter AG, Hospira, B.Braun Melsungen AG, etc. will further bolster the market growth in the region.